Inventor
Gregory R. Mundy
Inventor
San Antonio, TX, US
Overview
Patents· 40 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07KPeptides11%
A61QSpecific use of cosmetics or similar toiletry preparations9%
C07DHeterocyclic compounds6%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
A61LMethods or apparatus for sterilising materials or objects in general1%
PatentTitleYear
8,299,046'Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth'20127,618,630'Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists'20097,211,252'Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists'20077,101,907'Topical administration of statins for treatment of bone disorders'20066,958,220'Inhibitors of proteasomal activity for stimulating hair growth'20056,902,721'Inhibitors of proteasomal activity for stimulating bone growth'20056,884,769'Inhibitors of proteasomal activity for stimulating hair growth'20056,838,436'Inhibitors of proteasomal activity for stimulating bone growth'20056,838,252'Inhibitors of proteasomal activity for stimulating hair growth'20056,720,344'Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants'20046,656,904'Inhibitors of proteasomal activity for stimulating bone and hair growth'20036,649,631'Compositions and methods for treating bone deficit conditions'20036,642,216'Isoprenoid pathway inhibitors for stimulating bone growth'20036,492,333'Treatment of myeloma bone disease with proteasomal and NF-B activity inhibitors'20026,462,019'Inhibitors of proteasomal activity and production for stimulating bone growth'20026,413,998'Compositions and methods for treating bone deficit conditions'20026,410,512'Inhibitors of proteasomal activity for stimulating hair growth'20026,410,521'Nutritional supplements for stimulating bone growth'20026,376,476'Isoprenoid pathway inhibitors for stimulating bone growth'20026,342,514'Compositions and methods for treating bone deficit conditions'20026,251,901'Compositions and methods for treating bone deficit conditions'20016,153,631'Compositions and methods for treating bone deficit conditions'20006,083,690'Methods and compositions for identifying osteogenic agents'20006,080,779'Compositions and methods for stimulating bone growth'20006,017,940'Compositions and methods for treating bone deficit conditions'20006,008,208'Compositions and methods for treating bone deficit conditions'19995,994,358'Compositions and methods for treating bone deficit conditions'19995,993,817'Method to ameliorate osteolysis and metastasis'19995,990,169'Compositions and methods for treating bone deficit conditions'19995,965,573'Compositions and methods for treating bone deficit conditions'19995,948,776'Compositions and methods for treating bone deficit conditions'19995,939,444'Compositions and methods for treating bone deficit conditions'19995,922,753'Methods for treating bone deficit conditions with benzothiazole'19995,919,808'Compositions and methods for treating bone deficit conditions'19995,914,233'Screening assay for the identification of agents which alter expression of PTH-rP'19995,656,598'Use of fibroblast growth factors to stimulate bone growth'19975,626,845'Method to ameliorate osteolysis and metastasis'19975,614,496'Use of fibroblast growth factors to stimulate bone growth'19975,599,708'Osteoclast growth regulating factors and antibodies'19975,408,041'Process of purifying antler-derived bone growth factors'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–1997Patents assigned to OSTEOSA INC (3)· patent assignee history
1995–2012Based in San Antonio, TX, US· patent location history
1999–2012Patents assigned to OSTEOSCREEN INC (26)· patent assignee history
1999–2002Patents assigned to ZYMOGENETICS INC (11)· patent assignee history
1999–2003Patents assigned to ZYMOGENETICS CORP (5)· patent assignee history
2003–2009Patents assigned to UNIV TEXAS (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OSTEOSCREEN INC | 26 | 1999–2012 |
| ZYMOGENETICS INC | 11 | 1999–2002 |
| ZYMOGENETICS CORP | 5 | 1999–2003 |
| UNIV TEXAS | 4 | 2003–2009 |
| OSTEOSA INC | 3 | 1995–1997 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Antonio, Texas, US | 40 | 1995–2012 |